Pepar 2.25G Injection is classified under ‘Antibiotics’ and is primarily utilized for the treatment of bacterial infections. It is effective against various types of hospital-acquired and ventilator-associated pneumonia, urinary tract infections, intra-abdominal infections, skin and soft tissue infections (including diabetic foot infections), as well as uterine infections. A bacterial infection arises when harmful bacteria proliferate within the body, leading to illness. These infections can affect any part of the body and can multiply rapidly.
Pepar 2.25G Injection comprises two active ingredients: Piperacillin (a Penicillin antibiotic) and Tazobactam (a beta-lactamase inhibitor). Piperacillin falls under the category of ‘Penicillin antibiotics’ and exhibits bactericidal properties against both gram-positive and gram-negative bacteria, including aerobic (requiring oxygen) and anaerobic (able to survive with minimal or no oxygen) types. It functions by binding to penicillin-binding proteins (PBPs) within the bacterial cell wall, thereby inhibiting cell wall synthesis. Tazobactam serves as a beta-lactamase inhibitor, targeting the enzymes produced by bacteria that confer multi-resistance to β-lactam antibiotics, such as penicillins and cephalosporins. In the context of Pepar 2.25G Injection, Tazobactam plays a crucial role in preventing bacteria from degrading Piperacillin.
The administration of Pepar 2.25G Injection will be carried out by a qualified healthcare professional. As with all medications, Pepar 2.25G Injection may lead to side effects, although not everyone experiences them. Common side effects include nausea, constipation, diarrhea, headaches, and sleep disturbances. Should any of these effects persist or worsen, it is important to seek medical advice without delay.
It is essential to inform your doctor about your medical history, particularly if you have any known allergies to antibiotics. Additionally, please notify your healthcare provider if you have any liver or kidney conditions, bleeding disorders, or seizures prior to using Pepar 2.25G Injection. Avoid using Pepar 2.25G Injection during vaccination periods.
